Blood Preparation Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Blood Preparation Market is Segmented by Product Type (Blood Components, Whole Blood, and Blood Derivatives), Blood Thinning Agents (Fibrinolytic, Anticoagulants, and Platelet Aggregation Inhibitor), Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, and Other Applications) and Geography (North America (United States, Canada, and Mexico), Europe ) Germany, United Kingdom, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Middle East and Africa (GCC, South Africa, and the Rest of Middle East and Africa), and South America Brazil, Argentina, and Rest of South America)). The report offers the value (in USD million) for the above segments.

Blood Preparation Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Blood Preparation Market Size

Blood Preparation Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 5.50 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Blood Preparation Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Blood Preparation Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Blood Preparation Market Analysis

The Blood Preparation Market is expected to register a CAGR of 5.5% during the forecast period.

The COVID-19 pandemic initially had a substantial impact on the blood preparation market. The strict lockdowns and government regulations intended to slow down the spread of COVID-19 resulted in a decrease in blood collection activities. For instance, according to an article published by PLoS One in March 2022, both active and inactive donors felt less responsible and less morally obliged to donate blood during the pandemic, which resulted in an overall negative effect on blood donation. The article also stated that the pandemic compromised blood donations and endangered the life-saving blood supply. Thus, the pandemic affected the market's growth significantly in its preliminary phase; however, the market has gained traction in the post-pandemic period, and it is expected to observe stable growth during the forecast period.

Furthermore, the growing demand for blood and its components in surgeries, growing government and private sector initiatives, and the increasing geriatric population are among the major factors driving the growth of the market studied. Currently, the number of surgeries is increasing, which, in turn, is increasing the demand for blood preparation products. Such factors are likely to contribute to the growth of the market studied. For instance, according to the data published by British Heart Foundation in December 2021, an estimated 32,938 completed heart operations and other heart procedures were performed in England in October 2021. Moreover, according to the article published by the Annals of Surgery in July 2021, in the United States, nearly nine major surgeries are performed annually for every 100 adults, and more than 1 in 7 Medicare beneficiaries underwent a major surgery over five years, representing almost 5 million unique adults. Hence, the rising number of surgeries is expected to create a demand for blood and its components, thus enhancing the market growth.

Growing initiatives by the government and private bodies to raise awareness regarding blood donations and saving patients with better network collaborations through hospitals and social networks have been observed in recent years.

In addition, new product launches and strategic activities by major players in the market are positively affecting the growth of the market studied. For example, in June 2021, the United States FDA approved Pradaxa (dabigatran etexilate) oral blood thinning pellets to treat children between 3 months to less than 12 years old with venous thromboembolism (a condition where blood clots form in the veins) directly after they have been treated with a blood thinner injected for at least five days. The FDA also approved Pradaxa oral pellets to prevent recurrent clots among patients 3 months to less than 12 years old who completed treatment for their first venous thromboembolism. Additionally, Pradaxa is the first FDA-approved blood thinning medication children can consume orally. Thus, due to product launches and partnerships among market players, the studied market is expected to have significant growth over the forecast period.

Therefore, all the factors above, such as the growing demand for blood and its components in surgeries, the new product launches, and strategic activities by major players in the market, are anticipated to witness growth over the analysis period. However, the risk of infection post-transfusion and irregular infrastructure scenario to preserve blood are likely to impede the market's growth.

Blood Preparation Industry Overview

The blood preparation market is fragmented due to the presence of several companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies with significant market shares that are well known. It includes AstraZeneca, Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb Company, Daiichi Sankyo, GlaxoSmithKline PLC, Leo Pharma, Pfizer Inc, Sanofi, and Grifols SA.

Blood Preparation Market Leaders

  1. Bayer AG

  2. Boehringer Ingelheim

  3. GlaxoSmithKline PLC

  4. Pfizer, Inc.

  5. Leo Pharma

  6. *Disclaimer: Major Players sorted in no particular order
Blood Preparation Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Blood Preparation Market News

  • November 2022- ImmunoTek Plasma opened a new plasma collection center in Indianapolis. They have plasma collection centers in 12 states and another Indiana location in Jeffersonville, United States.
  • February 2022- Bayer AG won fast-track status from United States drug regulators for a new blood thinner designed to prevent certain types of strokes as it seeks to follow up on the success of its anticoagulant, Xarelto.

Blood Preparation Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Demand of Blood and Its Components in Surgeries
    • 4.2.2 Growing Initiatives by Government and Private Sector
    • 4.2.3 Increasing Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Risk of Infection Post-Transfusion
    • 4.3.2 Irregular Infrastructure Scenario to Preserve Blood
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value in USD million)

  • 5.1 By Product Type
    • 5.1.1 Blood Components
    • 5.1.2 Whole Blood
    • 5.1.3 Blood Derivatives
  • 5.2 By Blood Thining Agents
    • 5.2.1 Fibrinolytic
    • 5.2.2 Anticoagulants
    • 5.2.3 Platelet Aggregation Inhibitor
  • 5.3 By Application
    • 5.3.1 Thrombocytosis
    • 5.3.2 Pulmonary Embolism
    • 5.3.3 Renal Impairment
    • 5.3.4 Other Applications
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AstraZeneca
    • 6.1.2 Bayer AG
    • 6.1.3 Boehringer Ingelheim
    • 6.1.4 Bristol-Myers Squibb Company
    • 6.1.5 Daiichi Sankyo
    • 6.1.6 GlaxoSmithKline PLC
    • 6.1.7 Leo Pharma
    • 6.1.8 Pfizer Inc
    • 6.1.9 Grifols SA
    • 6.1.10 Sanofi
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Blood Preparation Industry Segmentation

Blood preparation involves a typical blood establishment process from collection to storage and transfer to hospitals for critical cases. Blood becomes an essential factor during life-threatening conditions, supportive therapy for surgery, chemotherapy, and stem cell and organ transplantation. 

 The Blood Preparation Market is Segmented by Product Type (Blood Components, Whole Blood, and Blood Derivatives), Blood Thinning Agents (Fibrinolytic, Anticoagulants, and Platelet Aggregation Inhibitor), Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, and Other Applications) and Geography (North America (United States, Canada, and Mexico), Europe ) Germany, United Kingdom, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Middle East and Africa (GCC, South Africa, and the Rest of Middle East and Africa), and South America Brazil, Argentina, and Rest of South America)). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers value (in USD million) for the above segments.

By Product Type Blood Components
Whole Blood
Blood Derivatives
By Blood Thining Agents Fibrinolytic
Anticoagulants
Platelet Aggregation Inhibitor
By Application Thrombocytosis
Pulmonary Embolism
Renal Impairment
Other Applications
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Blood Preparation Market Research FAQs

What is the current Blood Preparation Market size?

The Blood Preparation Market is projected to register a CAGR of 5.5% during the forecast period (2025-2030)

Who are the key players in Blood Preparation Market?

Bayer AG, Boehringer Ingelheim, GlaxoSmithKline PLC, Pfizer, Inc. and Leo Pharma are the major companies operating in the Blood Preparation Market.

Which is the fastest growing region in Blood Preparation Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Blood Preparation Market?

In 2025, the North America accounts for the largest market share in Blood Preparation Market.

What years does this Blood Preparation Market cover?

The report covers the Blood Preparation Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Blood Preparation Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Blood Preparation Industry Report

Statistics for the 2025 Blood Preparation market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Blood Preparation analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Blood Preparation Report Snapshots